Table 4.
Anxiolytics | Maine Route(s) of Elimination | Possible Mechanisms of Interactions | |
---|---|---|---|
Inducing or Inhibiting Effects on CYP, UGT and P-gp | Main Active Metabolite | ||
Diazepam | CYP3A4 and CYP2C19 Conjugation of its active metabolites with glucuronic acid |
- | Desmethyldiazepam, oxazepam and temazepam |
Chlordiazepoxide | CYP3A4 | - | Desmethylchlordiazepoxide, demoxepam, desmethyldiazepam and oxazepam |
Oxazepam | Conjugation with glucuronic acid | - | - |
Clorazepate | CYP3A4 | - | Nordiazepam (further metabolized by hydroxylation to oxazepam) |
Lorazepam | Conjugation with glucuronic acid | - | - |
Alprazolam | CYP3A4 | - | - |
Buspirone | CYP3A4 | - | 1-(2-pyrimidinyl)-piperazine |
Note: Anxiolytics are listed in the same order they appear in the ATC system. For a source of references, see the SmPC or PI of each anxiolytic.
For abbreviations, see Table 2.